AMERICAN BATTERY TECHNOLOGY earnings release, May 12, 2026
Attachments
Seq Document Description
───────────────────────────────────────────────────────────────────────────────
2 ex99-1.htm Additional exhibit
Financial statements
Income Statement
Description — A reconciliation of cost of goods sold to cash-cost of goods sold (non-GAAP 1 ) and revenue to adjusted gross margin, for the three months ended March 31, 2026
| Amount ($M) | |
|---|---|
| Revenue | 7.8 |
| Cost of Goods Sold | -7.1 |
| Gross Margin | 0.7 |
Income Statement
Description — A reconciliation of cost of goods sold to cash-cost of goods sold (non-GAAP 1 ) and revenue to adjusted gross margin, for the three months ended March 31, 2026
| Amount ($M) | |
|---|---|
| Revenue | 7.8 |
| Cost of Goods Sold | -7.1 |
| Less: Depreciation Expense | -1 |
| Less: Stock-Based Compensation | -0.3 |
| Cash Cost of Goods Sold (non-GAAP1) | 5.8 |
| Adjusted Gross Margin (non-GAAP1) | 2 |
Income Statement
Three months ended March 31, 2026 — Unaudited Condensed Consolidated Statements of Operations
| Three months ended March 31, 2026 | Three months ended March 31, 2025 | Nine months ended March 31, 2026 | Nine months ended March 31, 2025 | ||
|---|---|---|---|---|---|
| Revenue | 7,811,229 | 979,977 | 13,508,649 | 1,514,377 | |
| Cost of goods sold | 7,073,480 | 3,669,937 | 17,886,919 | 9,518,321 | |
| Gross margin (loss) | 737,749 | -2,689,960 | -4,378,270 | -8,003,944 | |
| Expenses: | General and administrative | 29,841,644 | 3,665,608 | 37,379,145 | 16,348,471 |
| Expenses: | Research and development | 4,644,759 | 3,252,929 | 11,160,033 | 8,204,929 |
| Expenses: | Exploration costs | 657,021 | 1,036,584 | 1,496,072 | 1,691,659 |
| Expenses: | Total operating expenses | 35,143,424 | 7,955,121 | 50,035,250 | 26,245,059 |
| Expenses: | Net loss before other income (expense) | -34,405,675 | -10,645,081 | -54,413,520 | -34,249,003 |
| Other income (expense) | Interest income (expense) | 335,738 | -8,393 | 641,357 | -12,371 |
| Other income (expense) | Amortization and accretion of financing costs | -886,020 | -307,428 | -2,790,566 | |
| Other income (expense) | Change in fair value of derivative liability | 705,184 | |||
| Other income (expense) | Loss on debt extinguishment | -675,648 | |||
| Other income (expense) | Loss on private placement | -567,161 | |||
| Other income (expense) | Change in fair value of liability-classified financial instruments | 875,100 | |||
| Other income (expense) | Other income | 233,740 | 43,547 | 662,856 | 123,443 |
| Other income (expense) | Total other income (expense) | 569,478 | -850,866 | 996,785 | -2,342,019 |
| Other income (expense) | Net loss | -33,836,197 | -11,495,947 | -53,416,735 | -36,591,022 |
| Other income (expense) | Net loss per share, basic and diluted | -0.26 | -0.14 | -0.43 | -0.48 |
| Other income (expense) | Weighted average shares outstanding | 131,855,794 | 85,090,957 | 124,415,975 | 76,553,029 |
Balance Sheet
March 31, 2026 — Unaudited Condensed Consolidated Balance Sheets
| March 31, 2026 | June 30, 2025 | ||
|---|---|---|---|
| ASSETS | Cash | 37,685,027 | 7,474,304 |
| ASSETS | Accounts receivable | 7,774,982 | 2,799,603 |
| ASSETS | Inventories (Note 4) | 846,603 | 408,147 |
| ASSETS | Grants receivable (Note 5) | 244,238 | |
| ASSETS | Prepaid expenses and other | 2,556,902 | 2,884,899 |
| ASSETS | Subscription receivable | 925,077 | |
| ASSETS | Restricted cash | 800,000 | 5,000,000 |
| ASSETS | Assets held-for-sale (Note 7) | 3,752,344 | 9,795,842 |
| ASSETS | Total current assets | 53,415,858 | 29,532,110 |
| ASSETS | Property and equipment, net (Note 6) | 55,231,160 | 45,469,853 |
| ASSETS | Mining properties (Note 8) | 9,710,716 | 8,392,977 |
| ASSETS | Intangible assets (Note 9) | 866,248 | 766,694 |
| ASSETS | Right-of-use asset (Note 12) | 204,246 | 296,157 |
| ASSETS | Total assets | 119,428,228 | 84,457,791 |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Accounts payable and accrued liabilities (Note 10) | 6,452,873 | 5,822,987 |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Operating lease liability (Note 12) | 127,315 | 115,863 |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Notes payable (Note 11) | 7,729,755 | |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Total current liabilities | 6,580,188 | 13,668,605 |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Operating lease liability, long-term | 93,274 | 190,163 |
| LIABILITIES & STOCKHOLDERS’ EQUITY | Total liabilities | 6,673,462 | 13,858,768 |
| STOCKHOLDERS’ EQUITY | Common Stock Authorized: 250,000,000 common shares, par value of $0.001 per share; Issued and outstanding: 132,271,860 and 97,398,519 common shares as of March 31, 2026 and June 30, 2025, respectively | 132,271 | 97,396 |
| STOCKHOLDERS’ EQUITY | Additional paid-in capital | 426,130,186 | 329,667,507 |
| STOCKHOLDERS’ EQUITY | Common stock issuable | 925,077 | |
| STOCKHOLDERS’ EQUITY | Accumulated deficit | -313,507,691 | -260,090,957 |
| STOCKHOLDERS’ EQUITY | Total stockholders’ equity | 112,754,766 | 70,599,023 |
| STOCKHOLDERS’ EQUITY | Total liabilities and stockholders’ equity | 119,428,228 | 84,457,791 |